RavenQuest BioMed Inc. (RVVQF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 8, 2025
RavenQuest BioMed Balance Sheet
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | 2009 - 2013 |
---|---|---|---|---|---|---|---|
Period Ending | Jul '19 Jul 31, 2019 | Oct '18 Oct 31, 2018 | Oct '17 Oct 31, 2017 | Oct '16 Oct 31, 2016 | Oct '15 Oct 31, 2015 | Oct '14 Oct 31, 2014 | 2009 - 2013 |
Cash & Equivalents | 0.75 | 0.36 | 3.38 | 0 | 0 | 0.01 | Upgrade
|
Cash & Short-Term Investments | 0.75 | 0.36 | 3.38 | 0 | 0 | 0.01 | Upgrade
|
Cash Growth | -44.99% | -89.27% | 559478.81% | -60.42% | -83.75% | 815.50% | Upgrade
|
Accounts Receivable | 0.63 | 0.21 | 0.14 | - | - | - | Upgrade
|
Other Receivables | 0.29 | 0.79 | 0.05 | 0 | 0 | 0 | Upgrade
|
Receivables | 0.92 | 1.01 | 0.18 | 0 | 0 | 0 | Upgrade
|
Inventory | 0.75 | 0.08 | - | - | - | - | Upgrade
|
Prepaid Expenses | 0.34 | 0.89 | 0.1 | - | - | - | Upgrade
|
Total Current Assets | 2.75 | 2.34 | 3.67 | 0 | 0 | 0.01 | Upgrade
|
Property, Plant & Equipment | 20.28 | 17.04 | 1.19 | - | - | 0 | Upgrade
|
Other Intangible Assets | 16.45 | 18.33 | 3.83 | - | - | - | Upgrade
|
Other Long-Term Assets | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Total Assets | 39.48 | 37.7 | 8.7 | 0.01 | 0.01 | 0.01 | Upgrade
|
Accounts Payable | 2.31 | 2.03 | 0.88 | 0.17 | 0.17 | 0.16 | Upgrade
|
Accrued Expenses | - | - | - | - | 0.16 | 0.11 | Upgrade
|
Short-Term Debt | 1.46 | - | 0.23 | 0.08 | 0.05 | 0.04 | Upgrade
|
Other Current Liabilities | 0.02 | 0.02 | 0.01 | 0.21 | - | - | Upgrade
|
Total Current Liabilities | 5.63 | 2.06 | 1.13 | 0.46 | 0.38 | 0.31 | Upgrade
|
Long-Term Debt | 13.32 | 13.26 | - | - | - | - | Upgrade
|
Total Liabilities | 18.95 | 15.32 | 1.13 | 0.46 | 0.38 | 0.31 | Upgrade
|
Common Stock | 58.03 | 51.95 | 13.1 | 1.83 | 1.83 | 1.83 | Upgrade
|
Retained Earnings | -45.58 | -36.05 | -5.58 | -2.28 | -2.2 | -2.13 | Upgrade
|
Comprehensive Income & Other | 8.08 | 6.49 | 0.05 | - | - | - | Upgrade
|
Total Common Equity | 20.53 | 22.39 | 7.57 | -0.45 | -0.37 | -0.29 | Upgrade
|
Minority Interest | - | - | 0 | - | - | - | Upgrade
|
Shareholders' Equity | 20.53 | 22.39 | 7.57 | -0.45 | -0.37 | -0.29 | Upgrade
|
Total Liabilities & Equity | 39.48 | 37.7 | 8.7 | 0.01 | 0.01 | 0.01 | Upgrade
|
Total Debt | 14.78 | 13.26 | 0.23 | 0.08 | 0.05 | 0.04 | Upgrade
|
Net Cash (Debt) | -14.03 | -12.9 | 3.15 | -0.08 | -0.05 | -0.03 | Upgrade
|
Net Cash Per Share | -0.12 | -0.14 | 0.10 | -0.00 | -0.00 | -0.00 | Upgrade
|
Filing Date Shares Outstanding | 123.91 | 113.08 | 72.27 | 29 | 29 | 29 | Upgrade
|
Total Common Shares Outstanding | 123.62 | 112.85 | 72.27 | 29 | 29 | 29 | Upgrade
|
Working Capital | -2.88 | 0.28 | 2.54 | -0.45 | -0.37 | -0.3 | Upgrade
|
Book Value Per Share | 0.17 | 0.20 | 0.10 | -0.02 | -0.01 | -0.01 | Upgrade
|
Tangible Book Value | 4.09 | 4.06 | 3.73 | -0.45 | -0.37 | -0.29 | Upgrade
|
Tangible Book Value Per Share | 0.03 | 0.04 | 0.05 | -0.02 | -0.01 | -0.01 | Upgrade
|
Machinery | 5.86 | 3.83 | 0.18 | - | - | - | Upgrade
|
Leasehold Improvements | 15.32 | 13.51 | 1.01 | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.